ICOSLG Antikörper (AA 19-258)
Kurzübersicht für ICOSLG Antikörper (AA 19-258) (ABIN2287330)
Target
Alle ICOSLG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 19-258
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- ICOS Ligand (CD275, Inducible T cell Co-stimulator Ligand, B7-H2, B7 Homolog 2, B7-like Protein Gl50, B7 Related Protein 1, B7H2, B7RP-1, B7RP1, GL50, ICOS LG , ICOSLG, KIAA0653, LICOS, Transmembrane Protein B7 H2 ICOS Ligand)
-
Aufreinigung
- Purified by Protein G affinity chromatography.
-
Endotoxin-Niveau
- Endotoxin: <0.1EU/ug (LAL)
-
Immunogen
- Recombinant protein corresponding to aa19-258 from human ICOS Ligand, expressed in NS0 cells (Accession #O75144
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 1 mL sterile PBS.
-
Buffer
- Supplied as a lyophilized powder from PBS, 5 % trehalose.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Andere Bezeichnung
- ICOS Ligand
-
UniProt
- O75144
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-